Pharmacy Drugs
Recent Posts
- Malignant Brain Tumors: Chemotherapy Alone Is Just As Effective As Radiation / New Positive Prognostic Factor Found
- Positive Interim Data From Minnow Medical Peripheral Artery Disease Trial Presented At TCT 2009 Conference
- Intercept Pharmaceuticals’ FXR Agonist INT-747 Meets Primary Endpoint In A Phase II Clinical Trial In Type 2 Diabetic Patients
- Largest Clinical Trial To Test Benefits Of Aspirin In Australia
- University Of Florida To Receive $29.5 Million In Recovery Act Funds To Begin Study Of Whether Exercise Prevents Disability In Older Adults
Random Posts
- High Response Rate Experienced By Multiple Myeloma Patients Treated With New 3-Drug Combination
- FDA Approves Triple-Drug Antihypertensive Polypill
- Experimental Vaccine Shows Promise In Treating Precancerous Vulvar Growths, Study Says
- FDA Says Yes to Nonhormonal Menorrhagia Drug
- DaVita Study Demonstrates Clinical Application Of Sysmex Reticulocyte Hemoglobin Equivalent (RET-He) Parameter
- Potential New Drugs: 970 Million And Still Counting - Journal Of The American Chemical Society
- BENLYSTA™ Successful In Second Pivotal Clinical Trial
- Team-Based Care Involving A Pharmacist Improves Blood Pressure Control
- Pharmacists Should Be On High Alert When Selling Orlistat, Says Society
- Spicing Up The Effectiveness Of A Potential Disease-Fighter
Drug Maker Recalls Pediatric Tylenol Products
Posted by: admin in Pharmacy Drugs on October 01st, 2009
The maker of Children’s Tylenol has recalled several varieties of the product after discovering possible contamination with a Gram-negative bacteria, Burkholderia cepacia.
McNeil Consumer Healthcare informed physicians and other providers of the recall in a Sept. 18 letter. The company said no bacteria have been found in finished products, but the bacteria were detected in an examination of the bulk materials used to make the medicine.
The company cautioned that infection with the bacteria can be serious in high-risk persons, including those with pulmonary disease, cystic fibrosis, or immune systems that are otherwise compromised.
The recall covers 21 flavors of its pediatric acetaminophen product, including Children’s Tylenol Suspension 4 oz. strawberry, Children’s Tylenol Pediatric Suspension 1 oz. cherry, and Infants’ Tylenol Suspension Drops ½ oz. grape, manufactured from April 2008 through June 2008.
The recall does not apply to Children’s Tylenol Meltaways and Junior Strength Tylenol Meltaways.
A complete list of affected lots is available from the manufacturer.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.
| Copyright 2009 |online pharmacy ambien no prescription buy xanax online no prescription online tramadol buying xanax online buy soma